Ledger.Open graph →

SEC Form D · filed September 2, 2022

Biolexis Therapeutics, Inc

Offering

—

Sold

$1.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SANDY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Dr. Hariprasad J. Vankayalapati · Sandy, UTExec Dr. David J. Bearss · Sandy, UTExec David O. Taylor · Sandy, UTExec Dr. Hariprasad J. Vankayalapati · Sandy, UTExec Dr. David J. Bearss · Sandy, UTExec David O. Taylor · Sandy, UTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗